US Patent 9545441 Treatment of diabetes
All edits
Edits on 17 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+297 characters)
Article
Patent abstract
Glycated hemoglobin (HbA1c) levels and other characteristics of diabetes are reduced by administering to a human subject a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
John Simard0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09545441 Treatment of diabetes US Patent 9545441 Treatment of diabetes
Infobox
Patent Number
09545441
Patent Number
9545441
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09545441 Treatment of diabetes
Infobox
Is a
Patent jurisdiction
Patent number
09545441
Date of patent
January 17, 2017
Patent application number
14030561
Date Filed
September 18, 2013
Patent primary examiner
Find more entities like US Patent 9545441 Treatment of diabetes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
